Accelerate Diagnostics, Inc. (AXDX)
USD 0.7
(-0.71%)
USD 0.7
(-0.71%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -61.61 Million USD | 1.4% |
| 2022 | -62.49 Million USD | 19.57% |
| 2021 | -77.7 Million USD | 0.65% |
| 2020 | -78.2 Million USD | 7.23% |
| 2019 | -84.3 Million USD | 4.55% |
| 2018 | -88.32 Million USD | -40.46% |
| 2017 | -62.88 Million USD | 5.26% |
| 2016 | -66.37 Million USD | -45.88% |
| 2015 | -45.49 Million USD | -47.09% |
| 2014 | -30.93 Million USD | -102.42% |
| 2013 | -15.28 Million USD | -187.74% |
| 2012 | -5.31 Million USD | -1302.2% |
| 2011 | -378.76 Thousand USD | -159.02% |
| 2010 | 641.74 Thousand USD | 189.86% |
| 2009 | -714.19 Thousand USD | 57.5% |
| 2008 | -1.68 Million USD | 12.68% |
| 2007 | -1.92 Million USD | 36.51% |
| 2006 | -3.03 Million USD | -44.95% |
| 2005 | -2.09 Million USD | -129.9% |
| 2004 | -909.42 Thousand USD | 33.9% |
| 2003 | -1.37 Million USD | -243.33% |
| 2002 | -400.73 Thousand USD | 74.09% |
| 2001 | -1.54 Million USD | -67.66% |
| 2000 | -922.53 Thousand USD | -1409.83% |
| 1999 | 70.43 Thousand USD | -97.55% |
| 1998 | 2.87 Million USD | 187.85% |
| 1997 | 1 Million USD | -9.09% |
| 1996 | 1.1 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -14.23 Million USD | -9.46% |
| 2024 Q2 | -11.58 Million USD | 18.57% |
| 2023 FY | -61.61 Million USD | 1.4% |
| 2023 Q1 | -17.94 Million USD | -21.26% |
| 2023 Q3 | 910 Thousand USD | 103.5% |
| 2023 Q4 | -13 Million USD | -1528.57% |
| 2023 Q2 | -25.98 Million USD | -44.77% |
| 2022 FY | -62.49 Million USD | 19.57% |
| 2022 Q4 | -14.8 Million USD | 11.06% |
| 2022 Q3 | -16.64 Million USD | 5.55% |
| 2022 Q1 | -12.47 Million USD | 45.29% |
| 2022 Q2 | -17.61 Million USD | -41.22% |
| 2021 Q1 | -24.23 Million USD | -28.17% |
| 2021 FY | -77.7 Million USD | 0.65% |
| 2021 Q2 | -21.67 Million USD | 10.58% |
| 2021 Q4 | -22.8 Million USD | -153.76% |
| 2021 Q3 | -8.98 Million USD | 58.54% |
| 2020 Q3 | -18.75 Million USD | 2.46% |
| 2020 Q4 | -18.91 Million USD | -0.83% |
| 2020 FY | -78.2 Million USD | 7.23% |
| 2020 Q1 | -21.3 Million USD | 0.12% |
| 2020 Q2 | -19.23 Million USD | 9.76% |
| 2019 Q2 | -20.81 Million USD | 4.17% |
| 2019 Q3 | -20.43 Million USD | 1.83% |
| 2019 Q1 | -21.72 Million USD | 2.12% |
| 2019 FY | -84.3 Million USD | 4.55% |
| 2019 Q4 | -21.33 Million USD | -4.41% |
| 2018 Q2 | -23.22 Million USD | -11.59% |
| 2018 FY | -88.32 Million USD | -40.46% |
| 2018 Q4 | -22.19 Million USD | -0.42% |
| 2018 Q3 | -22.09 Million USD | 4.85% |
| 2018 Q1 | -20.81 Million USD | -27.72% |
| 2017 Q1 | -14.2 Million USD | 11.99% |
| 2017 Q2 | -16.45 Million USD | -15.89% |
| 2017 Q3 | -17.07 Million USD | -3.76% |
| 2017 Q4 | -16.29 Million USD | 4.57% |
| 2017 FY | -62.88 Million USD | 5.26% |
| 2016 Q1 | -15.07 Million USD | -14.52% |
| 2016 Q4 | -16.13 Million USD | 6.73% |
| 2016 Q2 | -17.86 Million USD | -18.52% |
| 2016 Q3 | -17.29 Million USD | 3.17% |
| 2016 FY | -66.37 Million USD | -45.88% |
| 2015 Q3 | -11.18 Million USD | 8.7% |
| 2015 Q4 | -13.16 Million USD | -17.67% |
| 2015 FY | -45.49 Million USD | -47.09% |
| 2015 Q1 | -8.89 Million USD | -1.51% |
| 2015 Q2 | -12.25 Million USD | -37.71% |
| 2014 Q1 | -5.2 Million USD | -0.83% |
| 2014 Q4 | -8.76 Million USD | 0.56% |
| 2014 Q3 | -8.81 Million USD | -8.12% |
| 2014 FY | -30.93 Million USD | -102.42% |
| 2014 Q2 | -8.15 Million USD | -56.71% |
| 2013 Q2 | -3.77 Million USD | -48.14% |
| 2013 Q3 | -3.79 Million USD | -0.53% |
| 2013 FY | -15.28 Million USD | -187.74% |
| 2013 Q4 | -5.15 Million USD | -35.89% |
| 2013 Q1 | -2.54 Million USD | 12.12% |
| 2012 Q2 | -4.16 Million USD | -973.46% |
| 2012 Q3 | -1.66 Million USD | 60.06% |
| 2012 FY | -5.31 Million USD | -1302.2% |
| 2012 Q4 | -2.9 Million USD | -74.22% |
| 2012 Q1 | -388.38 Thousand USD | -20.17% |
| 2011 FY | -378.76 Thousand USD | -159.02% |
| 2011 Q4 | -323.18 Thousand USD | 24.89% |
| 2011 Q2 | -295.65 Thousand USD | -138.45% |
| 2011 Q1 | -123.99 Thousand USD | -370.39% |
| 2011 Q3 | -430.27 Thousand USD | -45.53% |
| 2010 Q2 | 1.79 Million USD | 597.86% |
| 2010 Q4 | -26.36 Thousand USD | -139.2% |
| 2010 Q3 | 67.25 Thousand USD | -96.26% |
| 2010 FY | 641.74 Thousand USD | 189.86% |
| 2010 Q1 | -361.14 Thousand USD | 5.74% |
| 2009 Q4 | -383.12 Thousand USD | 7.0% |
| 2009 FY | -714.19 Thousand USD | 57.5% |
| 2009 Q1 | -208.92 Thousand USD | -35.38% |
| 2009 Q2 | -126.84 Thousand USD | 39.29% |
| 2009 Q3 | -411.98 Thousand USD | -224.8% |
| 2008 Q3 | -224.09 Thousand USD | 53.53% |
| 2008 Q1 | -370.76 Thousand USD | -8.97% |
| 2008 FY | -1.68 Million USD | 12.68% |
| 2008 Q4 | -154.33 Thousand USD | 31.13% |
| 2008 Q2 | -482.21 Thousand USD | -30.06% |
| 2007 Q1 | -476.53 Thousand USD | -4.42% |
| 2007 Q3 | -487.12 Thousand USD | -7.77% |
| 2007 Q2 | -452.01 Thousand USD | 5.15% |
| 2007 FY | -1.92 Million USD | 36.51% |
| 2007 Q4 | -340.24 Thousand USD | 30.15% |
| 2006 Q4 | -456.35 Thousand USD | 15.38% |
| 2006 Q3 | -539.33 Thousand USD | 21.05% |
| 2006 Q2 | -683.15 Thousand USD | 13.4% |
| 2006 Q1 | -788.86 Thousand USD | -0.42% |
| 2006 FY | -3.03 Million USD | -44.95% |
| 2005 Q2 | -703.64 Thousand USD | -25.02% |
| 2005 Q3 | -772.03 Thousand USD | -9.72% |
| 2005 Q1 | -562.83 Thousand USD | -78.87% |
| 2005 FY | -2.09 Million USD | -129.9% |
| 2005 Q4 | -785.54 Thousand USD | -1.75% |
| 2004 Q2 | 220.23 Thousand USD | 165.83% |
| 2004 Q4 | -314.66 Thousand USD | 38.28% |
| 2004 Q1 | -334.53 Thousand USD | 10.1% |
| 2004 Q3 | -509.8 Thousand USD | -331.48% |
| 2004 FY | -909.42 Thousand USD | 33.9% |
| 2003 Q2 | -776.99 Thousand USD | -353.17% |
| 2003 FY | -1.37 Million USD | -243.33% |
| 2003 Q1 | -171.45 Thousand USD | 16.06% |
| 2003 Q3 | -422.99 Thousand USD | 45.56% |
| 2003 Q4 | -372.12 Thousand USD | 12.03% |
| 2002 Q1 | -150.9 Thousand USD | -4.34% |
| 2002 FY | -400.73 Thousand USD | 74.09% |
| 2002 Q4 | -204.26 Thousand USD | 8.44% |
| 2002 Q3 | -223.1 Thousand USD | -259.03% |
| 2002 Q2 | 140.28 Thousand USD | 192.96% |
| 2001 Q2 | -749.16 Thousand USD | -114.74% |
| 2001 Q3 | -245.48 Thousand USD | 67.23% |
| 2001 Q4 | -144.63 Thousand USD | 41.08% |
| 2001 FY | -1.54 Million USD | -67.66% |
| 2001 Q1 | -348.87 Thousand USD | -30.34% |
| 2000 Q3 | -181 Thousand USD | -33.32% |
| 2000 FY | -922.53 Thousand USD | -1409.83% |
| 2000 Q2 | -135.76 Thousand USD | 75.73% |
| 2000 Q1 | -559.4 Thousand USD | -538.29% |
| 2000 Q4 | -267.66 Thousand USD | -47.88% |
| 1999 FY | 70.43 Thousand USD | -97.55% |
| 1999 Q4 | -87.64 Thousand USD | 37.28% |
| 1999 Q3 | -139.72 Thousand USD | -1926.95% |
| 1999 Q2 | 7648.00 USD | 108.85% |
| 1999 Q1 | -86.44 Thousand USD | -223.9% |
| 1998 Q1 | 1.2 Million USD | 5.4% |
| 1998 Q4 | 69.77 Thousand USD | -12.19% |
| 1998 Q3 | 79.45 Thousand USD | 127.8% |
| 1998 FY | 2.87 Million USD | 187.85% |
| 1998 Q2 | -285.81 Thousand USD | -123.82% |
| 1997 Q1 | 400 Thousand USD | 300.0% |
| 1997 Q2 | 300 Thousand USD | -25.0% |
| 1997 Q3 | 868.19 Thousand USD | 189.4% |
| 1997 Q4 | 1.13 Million USD | 31.13% |
| 1997 FY | 1 Million USD | -9.09% |
| 1996 Q2 | 500 Thousand USD | 25.0% |
| 1996 Q3 | 200 Thousand USD | -60.0% |
| 1996 FY | 1.1 Million USD | 0.0% |
| 1996 Q4 | 100 Thousand USD | -50.0% |
| 1996 Q1 | 400 Thousand USD | 100.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 200 Thousand USD | 100.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 24.546% |
| Cerus Corporation | -37.48 Million USD | -64.363% |
| OrthoPediatrics Corp. | -20.97 Million USD | -193.783% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -462.449% |
| Talis Biomedical Corporation | -62 Million USD | 0.627% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -353.641% |
| Inogen, Inc. | -102.44 Million USD | 39.855% |
| Spectral AI, Inc. | -20.85 Million USD | -195.473% |
| Nano-X Imaging Ltd. | -60.77 Million USD | -1.385% |
| CVRx, Inc. | -41.19 Million USD | -49.562% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 9724.865% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -596.249% |
| Orthofix Medical Inc. | -151.39 Million USD | 59.3% |
| Venus Concept Inc. | -37.25 Million USD | -65.417% |
| Bioventus Inc. | -156.23 Million USD | 60.559% |
| BrainsWay Ltd. | -4.19 Million USD | -1368.144% |
| Envoy Medical, Inc. | -29.9 Million USD | -106.025% |
| electroCore, Inc. | -18.83 Million USD | -227.164% |
| IceCure Medical Ltd | -14.65 Million USD | -320.543% |
| Lucid Diagnostics Inc. | -52.66 Million USD | -16.998% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -348.287% |
| MaxCyte, Inc. | -37.92 Million USD | -62.482% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -419.567% |
| Nexalin Technology, Inc. | -4.64 Million USD | -1225.486% |
| PAVmed Inc | -64.17 Million USD | 3.984% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | -17.441% |
| RxSight, Inc. | -48.6 Million USD | -26.765% |
| Sight Sciences, Inc. | -55.54 Million USD | -10.929% |
| SI-BONE, Inc. | -43.33 Million USD | -42.187% |
| TELA Bio, Inc. | -46.66 Million USD | -32.046% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | -4.37% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | -24.413% |
| LivaNova PLC | 17.54 Million USD | 451.18% |
| 908 Devices Inc. | -36.39 Million USD | -69.285% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 66.985% |
| Nemaura Medical Inc. | -14.14 Million USD | -335.656% |
| NeuroPace, Inc. | -32.95 Million USD | -86.971% |
| LENSAR, Inc. | -14.38 Million USD | -328.409% |
| Apyx Medical Corporation | -18.71 Million USD | -229.279% |
| Cutera, Inc. | -162.83 Million USD | 62.159% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -468.957% |
| BioSig Technologies, Inc. | -29.04 Million USD | -112.176% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 25.462% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -178.953% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 190.961% |
| Axonics, Inc. | -6.08 Million USD | -912.122% |
| Outset Medical, Inc. | -172.79 Million USD | 64.341% |
| IRIDEX Corporation | -9.57 Million USD | -543.866% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 41.813% |
| IRadimed Corporation | 17.19 Million USD | 458.395% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -647.428% |
| INVO Bioscience, Inc. | -8.03 Million USD | -666.907% |
| Telesis Bio, Inc. | -47.72 Million USD | -29.113% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 701.562% |
| Varex Imaging Corporation | -47.7 Million USD | -29.178% |
| Quipt Home Medical Corp. | -2.78 Million USD | -2113.29% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -445.968% |
| Pulmonx Corporation | -60.84 Million USD | -1.274% |
| Dynatronics Corporation | -2.69 Million USD | -2184.078% |
| Modular Medical, Inc. | -17.47 Million USD | -252.707% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -441.126% |
| Semler Scientific, Inc. | 20.58 Million USD | 399.364% |
| InMode Ltd. | 197.91 Million USD | 131.133% |
| Bruker Corporation | 427.2 Million USD | 114.424% |
| Cytosorbents Corporation | -28.5 Million USD | -116.147% |
| DexCom, Inc. | 541.5 Million USD | 111.379% |
| Align Technology, Inc. | 445.05 Million USD | 113.845% |
| Viveve Medical, Inc. | -22.02 Million USD | -179.739% |
| ZimVie Inc. | -393.28 Million USD | 84.332% |
| Movano Inc. | -29.28 Million USD | -110.422% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -407.228% |
| Nexalin Technology, Inc. | -4.64 Million USD | -1225.486% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 9724.865% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 72.32% |
| Profound Medical Corp. | -28.56 Million USD | -115.681% |
| Insulet Corporation | 206.3 Million USD | 129.868% |
| enVVeno Medical Corporation | -23.51 Million USD | -162.026% |
| Surmodics, Inc. | -11.54 Million USD | -433.859% |
| iCAD, Inc. | -4.84 Million USD | -1171.261% |
| Nuwellis, Inc. | -20.2 Million USD | -204.904% |
| Biotricity, Inc. | -14.09 Million USD | -337.184% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 50.069% |
| Aethlon Medical, Inc. | -12.2 Million USD | -404.727% |
| InspireMD, Inc. | -19.91 Million USD | -209.389% |
| PAVmed Inc. | -64.17 Million USD | 3.984% |
| BIOLASE, Inc. | -20.63 Million USD | -198.653% |
| Beyond Air, Inc. | -60.24 Million USD | -2.284% |
| FONAR Corporation | 10.56 Million USD | 683.095% |
| AxoGen, Inc. | -21.71 Million USD | -183.745% |
| Vivani Medical, Inc. | -25.65 Million USD | -140.207% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 316.09% |
| Inari Medical, Inc. | -1.63 Million USD | -3666.381% |
| UFP Technologies, Inc. | 44.92 Million USD | 237.161% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -1100.585% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -832.87% |
| Tenon Medical, Inc. | -15.58 Million USD | -295.469% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -299.442% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -74.393% |
| AdaptHealth Corp. | -678.89 Million USD | 90.924% |
| Sintx Technologies, Inc. | -8.25 Million USD | -646.071% |
| NanoVibronix, Inc. | -3.71 Million USD | -1560.415% |
| Quanterix Corporation | -32.33 Million USD | -90.567% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -445.968% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 12804.742% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 79.912% |
| TransMedics Group, Inc. | -25.02 Million USD | -146.196% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -178.399% |
| NeuroMetrix, Inc. | -6.52 Million USD | -843.688% |
| Hyperfine, Inc. | -44.23 Million USD | -39.287% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 21.508% |
| Biomerica, Inc. | -5.97 Million USD | -930.746% |
| Bone Biologics Corporation | -8.94 Million USD | -588.567% |
| AVITA Medical, Inc. | -39.16 Million USD | -57.316% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -519.034% |
| Silk Road Medical, Inc | -55.74 Million USD | -10.539% |